NYSE:PRGOPharmaceuticals
Perrigo (PRGO) Stock Looks Undervalued Despite Weak Returns And Cash Flow Risk
Perrigo stock is trading at US$10.72 after a long stretch of weak returns, and the valuation checks now suggest the market may be pricing the shares more cautiously than the fundamentals alone would indicate.
Perrigo shareholders have seen the stock fall 71.3% over the past 5 years, which raises the question of whether expectations have simply moved too far the other way.
For the valuation to hold up, the key support will come from Perrigo’s ability to convert its healthcare portfolio into...